Renaissance Technologies’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $740K | Sell |
164,100
-92,606
| -36% | -$418K | ﹤0.01% | 2648 |
|
|
2025
Q1 | $1.14M | Buy |
256,706
+125,106
| +95% | +$554K | ﹤0.01% | 2337 |
|
|
2024
Q4 | $1.03M | Buy |
131,600
+103,700
| +372% | +$812K | ﹤0.01% | 2486 |
|
|
2024
Q3 | $367K | Sell |
27,900
-36,737
| -57% | -$483K | ﹤0.01% | 2905 |
|
|
2024
Q2 | $781K | Sell |
64,637
-50,663
| -44% | -$612K | ﹤0.01% | 2461 |
|
|
2024
Q1 | $1.88M | Sell |
115,300
-59,500
| -34% | -$968K | ﹤0.01% | 2075 |
|
|
2023
Q4 | $1.19M | Sell |
174,800
-62,290
| -26% | -$425K | ﹤0.01% | 2287 |
|
|
2023
Q3 | $1.29M | Buy |
237,090
+20,890
| +10% | +$114K | ﹤0.01% | 2130 |
|
|
2023
Q2 | $1.47M | Buy |
216,200
+128,800
| +147% | +$875K | ﹤0.01% | 2202 |
|
|
2023
Q1 | $438K | Buy |
87,400
+33,900
| +63% | +$170K | ﹤0.01% | 2951 |
|
|
2022
Q4 | $261K | Sell |
53,500
-74,400
| -58% | -$363K | ﹤0.01% | 3293 |
|
|
2022
Q3 | $1.84M | Sell |
127,900
-21,900
| -15% | -$316K | ﹤0.01% | 2063 |
|
|
2022
Q2 | $2.27M | Buy |
149,800
+58,800
| +65% | +$889K | ﹤0.01% | 2100 |
|
|
2022
Q1 | $1.08M | Sell |
91,000
-7,600
| -8% | -$90.3K | ﹤0.01% | 2678 |
|
|
2021
Q4 | $1.6M | Buy |
+98,600
| New | +$1.6M | ﹤0.01% | 2323 |
|
|
2021
Q2 | – | Sell |
-32,200
| Closed | -$974K | – | 3822 |
|
|
2021
Q1 | $974K | Buy |
+32,200
| New | +$974K | ﹤0.01% | 2620 |
|
|
2020
Q1 | – | Sell |
-26,000
| Closed | -$813K | – | 3869 |
|
|
2019
Q4 | $813K | Sell |
26,000
-44,700
| -63% | -$1.4M | ﹤0.01% | 2721 |
|
|
2019
Q3 | $1.84M | Buy |
70,700
+28,900
| +69% | +$753K | ﹤0.01% | 2323 |
|
|
2019
Q2 | $956K | Buy |
+41,800
| New | +$956K | ﹤0.01% | 2701 |
|